目的：探讨机器人McKeown 食管癌切除术的临床应用，评估其安全性和短期疗效。方法：回顾性分析2017 年6 月~2019 年12 月单一手术组行机器人McKeown 食管癌切除术121 例患者的临床资料和短期临床结果。结果：121 例患者中位年龄60（34~77）岁，其中男100 例，女21 例，32 例行新辅助治疗。平均手术时间（320.2±43.1）min，失血量（197.4±33.4）ml，每例淋巴结清扫23（5~71）个。术后病理证实鳞癌患者109 例；32 例行新辅助治疗的患者中，9 例获得病理完全缓解（28.1%）。74 例左喉返神经旁淋巴结清扫数目为4（1~13）个，转移率为21.6%（16/74）；101 例右喉返神经旁淋巴结清扫数目为3（1~13）个，转移率为18.8%（19/101）。术后总体并发症发生率为34.7%（42/121），包括声嘶17 例（14.0%）、肺炎13 例（10.7%）、吻合口瘘9 例（7.4%）、胸腔积液4 例（3.3%）、切口感染2 例（1.7%）、乳糜胸1 例（0.8%）、其他并发症共8 例；术后9 例患者入住ICU 时间5（1~21）d。全组患者无死亡病例，术后中位住院时间14（13~64）d。结论：机器人McKeown 食管癌切除术应用于食管癌安全可行，可获得较满意的短期疗效。

To investigate the clinical application of robot-assisted McKeown esophagectomy (RAME) and evaluate its safety and short-term outcomes. Methods: The clinical data and short-term outcomes of 121 patients underwent RAME from June 2017 to December 2019 in a single-operation group were retrospectively analyzed. Results: The median age of 121 patients was 60 (34~77) years old, including 100 males and 21 females, of which 32 patients received neoadjuvant therapy. The average operation time was (320.2±43.1)min, the blood loss was (197.4±33.4)ml and the median number of dissected lymph node was 23 (5~71). 109 patients were confirmed with squamous cell carcinoma by postoperative pathology, and 9 patients achieved pathological complete remission among 32 patients whom underwent neoadjuvant therapy (9/32, 28.1%). 74 cases underwent lymph node dissection at left laryngeal recurrent nerve (LRN) and the median number of dissected lymph node was 4 (1~13) with metastasis rate of 21.6% (16/74) . 101 cases underwent lymph node dissection at right LRN and the median number of dissected lymph node was 3 (1~13) with metastasis rate of 18.8% (19/101). The overall incidence of postoperative complication was 34.7% (42/121), including 17 cases of hoarseness, 13 cases of pneumonia, 9 cases of anastomotic leakages, 4 cases of pleural effusion, 2 cases of incision infection, 1 case of chylothorax, and 8 cases of other complications. Nine patients were admitted to the ICU after surgery, and the median ICU stay was 5 (1~21) d. No perioperative death was found, and the median postoperative hospital stay was 14 (13~64) d.

收稿日期：2020-03-02 录用日期：2020-07-21

Received Date: 2020-03-02 Accepted Date: 2020-07-21

基金项目：天津市教委基础科研项目（2018KJ070）；白求恩公益基因会卓越外科基金 （HZB-20181119-8）

Foundation Item: Basic Research Grant from Tianjin Municipal Education Commission (2018KJ070); Excellence in Surgery Grant from Bethune Charitable Foundation (HZB-20181119-8)

通讯作者：姜宏景，Email：jianghj@vip.163.com

Corresponding Author: JIANG Hongjing, Email: jianghj@vip. 163. com

引用格式：段晓峰，岳杰，陈传贵，等. 机器人辅助McKeown 食管癌切除术近期疗效分析[J]. 机器人外科学杂志，2020，1（5）：355-363.

Citation: DUAN X F, YUE J, CHEN C G, et al. Study on short-term effect of robot-assisted McKeown esophagectomy in esophageal cancer[J]. Chinese Journal of Robotic Surgery, 2020, 1(5): 355-363.

[1] Moon D H, Lee J M, Jeon J H, et al. Clinical outcomes of video-assisted thoracoscopic surgery esophagectomy for esophageal cancer: a propensity score-matched analysis[J]. J Thorac Dis, 2017, 9(9): 3005-3012. 

[2] Kauppila J H, Helminen O, Kyto V, et al. Short-Term Outcomes Following Minimally Invasive and Open Esophagectomy: A Population-Based Study from Finland and Sweden [J]. Ann Surg Oncol, 2018, 25(1): 326-332. 

[3] Takeuchi H, Miyata H, Ozawa S, et al. Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan [J]. Ann Surg Oncol, 2017, 24(7): 1821-1827. 

[4] Yamashita K, Watanabe M, Mine S, et al. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis [J]. Surg Endosc, 2018, 32(11): 4443-4450. 

[5] Mitzman B, Lutfi W, Wang C H, et al. Minimally Invasive Esophagectomy Provides Equivalent Survival to Open Esophagectomy: An Analysis of the National Cancer Database [J]. Semin Thorac Cardiovasc Surg, 2017, 29(2): 244-253. 

[6] Weksler B, Sullivan J L. Survival After Esophagectomy: A Propensity-Matched Study of Different Surgical Approaches [J]. Ann Thorac Surg, 2017, 104(4): 1138- 1146. 

[7] Straatman J, van der Wielen N, Cuesta M A, et al. Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial [J]. Ann Surg, 2017, 266(2): 232-236. 

[8] Kernstine K H, DeArmond D T, Karimi M, et al. The robotic, 2-stage, 3-field esophagolymphadenectomy [J]. J Thorac Cardiovasc Surg, 2004, 127(6): 1847-1849. 

[9] Park S Y, Kim D J , Yu W S, et al. Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer [J]. Dis Esophagus, 2016, 29(4): 326-332. 

[10] Suda K, Ishida Y, Kawamura Y, et al. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes [J]. World J Surg, 2012, 36(7): 1608-1616. 

[11] Park S, Hwang Y, Lee H J, et al. Comparison of robot-assisted esophagectomy and thoracoscopic esophagectomy in esophageal squamous cell carcinoma [J]. J Thorac Dis, 2016, 8(10): 2853-2861. 

[12] Park S, Hyun K, Lee H J, et al. A study of the learning curve for robotic oesophagectomy for oesophageal cancer [J]. Eur J Cardiothorac Surg, 2018, 53(4): 862-870. 

[13] CHEN J, LIU Q, ZHANG X, et al. Comparisons of short-term outcomes between robot-assisted and thoraco-laparoscopic esophagectomy with extended two-field lymph node dissection for resectable thoracic esophageal squamous cell carcinoma [J]. J Thorac Dis, 2019, 11(9): 3874-3880. 

[14] ZHANG Y, HAN Y, GAN Q, et al. Early Outcomes of Robot-Assisted Versus Thoracoscopic-Assisted Ivor Lewis Esophagectomy for Esophageal Cancer: A Propensity Score-Matched Study [J]. Ann Surg Oncol, 2019, 26(5): 1284-1291. 

[15] Yun J K, Chong B K, Kim H J, et al. Comparative outcomes of robot-assisted minimally invasive versus open esophagectomy in patients with esophageal squamous cell carcinoma: a propensity score-weighted analysis [J]. Dis Esophagus, 2019, 33(5): doz071. 

[16] van der Sluis P C, van der Horst S, May A M, et al. Robot-assisted Minimally Invasive Thoracolaparoscopic E s o p h a g e c t o m y V e r s u s O p e n T r a n s t h o r a c i c Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial [J]. Ann Surg, 2019, 269(4): 621-630. 

[17] van der Horst S, de Maat M F G, van der Sluis P C, et al. Extended thoracic lymph node dissection in roboticassisted minimal invasive esophagectomy (RAMIE) for patients with superior mediastinal lymph node metastasis [J]. Ann Cardiothorac Surg, 2019, 8(2): 218- 225. 

[18] Motoyama S, Sato Y, Wakita A, et al. Extensive Lymph Node Dissection Around the Left Laryngeal Nerve Achieved With Robot-assisted Thoracoscopic Esophagectomy [J]. Anticancer Res, 2019, 39(3): 1337- 1342. 

[19] Horgan S, Berger R A, Elli E F, et al. Robotic-assisted minimally invasive transhiatal esophagectomy[J]. Am Surg, 2003, 69 (7): 624-626. 

[20] van der Sluis P C, Ruurda J P, Verhage R J, et al. Oncologic Long-Term Results of Robot-Assisted M i n i m a l l y I n v a s i v e T h o r a c o - L a p a r o s c o p i c Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer[J]. Ann Surg Oncol, 2015, 22(Suppl 3): S1350-1356. 

[21] 易俊, 熊磊, 李德闽, 等. 达芬奇机器人在食管癌 外科治疗中的应用[J]. 中国胸心血管外科临床杂 志, 2015, 22 (10): 910-913. 

[22] 张晓彬, 杨煜, 叶波, 等. 达芬奇机器人手术系统 辅助与胸腹腔镜联合辅助食管癌根治术的疗效分 析[J]. 中华消化外科杂志, 2017, 16(8): 844-849. 

[23] Matsuda S, Takeuchi H, Kawakubo H, et al. Three-field lymph node dissection in esophageal cancer surgery[J]. J Thorac Dis, 2017, 9(Suppl 8): S731-S740. 

[24] Suda K, Ishida Y, Kawamura Y, et al. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes[J]. World J Surg, 2012, 36(7): 1608-1616. 

[25] YANG Y, ZHANG X, LI B, et al. Short- and midterm outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study[J]. Dis Esophagus, 2019. DOI: 10. 1093/dote/doz080.